Condensed Consolidated Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current Assets:
Cash	$ 3,811,014	$ 3,237,106
Accounts receivable, net	48,832	261,809
Other current assets, net	474,178	729,342
Deferred contract costs	66,300
Current assets held for sale		118,459
Total current assets	4,400,324	4,346,716
Other Assets		250,383
Intangible Assets, net	370,409	566,259
Goodwill	4,183,232	4,183,232
Non-current assets held for sale		27,595
Total assets	8,953,965	9,374,185
Current Liabilities:
Accounts payable and accrued expenses	989,538	1,154,072
Deferred revenue	103,052	81,318
Current liabilities held for sale		13,759
Total current liabilities	1,092,590	1,249,149
Non-current Liabilities:
Convertible debt	220,309	7,841,500
Accrued severance liability	325,000
Total liabilities	1,637,899	9,090,649
Commitments and Contingencies (Note 10)
Stockholders’ Equity:
Common stock, $0.0001 par value, 250,000,000 shares authorized; 7,874,962 and 3,179,789 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively	786	318
Additional paid in capital	163,613,111	140,257,448
Accumulated deficit	(156,310,215)	(140,130,159)
Accumulated comprehensive income	12,384	155,929
Total stockholders’ equity	7,316,066	283,536
Total liabilities and stockholders’ equity	$ 8,953,965	$ 9,374,185